Property

Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO

SwitchBot Launches SwitchBot Bot Rechargeable

Caliway’s Fat Reduction Drug CBL-514 Phase 2 Clinical Results Accepted by ASJ. CBL-0204’s Demonstrated Efficacy and Safety Gain Further Academic Recognition

Sam Docherty welcomed back to Carlton ahead of cancer charity game as Patrick Cripps says ‘no hard feelings’